[Nonsteroidal antiandrogenic monotherapy: compared to monotherapy with luteinizing hormone-releasing hormone agonists or surgical castration for advanced prostate cancer]

Urologe A. 2015 Jan;54(1):78-81. doi: 10.1007/s00120-014-3749-0.
[Article in German]
No abstract available

MeSH terms

  • Adult
  • Aged
  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use*
  • Castration*
  • Disease-Free Survival
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Receptors, LHRH / agonists*
  • Survival Rate
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Receptors, LHRH